Archive for the ‘Activism’ Category

Public Fear Brings Easy Money to Vaccine Committee Members

https://popularrationalism.substack.com/p/public-fear-brings-easy-money-to

Public Fear Brings Easy Money to Vaccine Committee Members

They deliberate and vote on your behalf. They are unelected. They are conflicted. They turn dozens of conflict-blinded eyes to clear signals of risk.
The following was published by Attorney Tom Renz. The original file is located here.

Gov/Big Pharma Conflict

The vaccine is called mRNA-1273 and was developed by NIAID scientists and their collaborators at the biotechnology company Moderna, Inc., based in Cambridge, Massachusetts. The Coalition for Epidemic Preparedness Innovations (CEPI) supported the manufacturing of the vaccine candidate for the Phase 1 clinical trial.

“Finding a safe and effective vaccine to prevent infection with SARS-CoV-2 is an urgent public health priority,” said NIAID Director Anthony S. Fauci, M.D. “This Phase 1 study, launched in record speed, is an important first step toward achieving that goal.”1

To receive a share of the profit from the sale of mRNA-1273, the inventors of this product within NIAID would submit an Employee Invention Report to the NIH Office of Technology transfer.2 Each inventor stands to receive a personal payment of up to $150k annually from the sales of mRNA-1273.3 In addition, NIAID stands to earn millions of dollars in revenue from the sale of mRNA-1273.4

Moderna will pay license fee to NIAID to use its patents related to mRNA-1273 and a portion of those fees are then paid directly to the inventors within NIAID who developed those patents.5 NIH has produced reports which confirm that these individuals are listed as inventors.6

• Barney Graham, Deputy Director, NIAID Vaccine Research Center

• Kizzmekia Shanta Corbett, Scientific Lead, NIAID’s Coronavirus Vaccine Program

• Michael Gordon Joyce, NIAID

• Hadi Yassine, NIAID

• Masaru Kanekiyo, NIAID

• Olubukola Abiona, NIAID

HHS awarded $483 million to accelerate development of mRNA-1273.7 The US Government has reached a 1.525 billion deal to purchase 100 million doses of mRNA-1273.8

In 2013, the Autonomous Diagnostics to Enable Prevention and Therapeutics (ADEPT) program awarded grant funding to Moderna Therapeutics for the development of a new type of vaccine based on messenger RNA. The initial DARPA grant was W911NF-13-1-0417. The company used that technology to develop its COVID-19 vaccine, currently undergoing Phase I clinical trials in conjunction with NIH. 9 2

FDA Vaccines and Related Biological Products Advisory Committee Roster Content current as of 4/9/2110

Any consideration of financial conflict of interest at the Vaccines and Related Biological Products Advisory Committee must be set against the historical backdrop of the profound financial conflicts of interest seen in the during the H1N1 pandemic ten years ago. At that time, five of the sixteen experts were found to have ties to the pharmaceutical industry. There were “calls from the British Medical Journal, to release the names of committee members and their conflicts of interest, in the interest of transparency and to monitor any possible commercial influence.” That earlier “pandemic has proved profit-making for the industry, with one estimate (by JP Morgan) putting 2009 vaccine profits alone at $7-10 billion.”11

There appear to be significant conflicts of interest today especially among committee leaders. The items reported in this memo are the results of a quick preliminary check on conflicts and are not a complete representation. Plaintiffs intend to conduct a more thorough investigation before trial.

Chair

Hana El Sahly, M.D.

Expertise: Vaccines, Infectious Diseases

Term: 06/21/2019-01/31/2022

Professor Department of Molecular Virology and Microbiology Department of Medicine Section of Infectious Diseases Baylor College of Medicine Houston, TX 77030 hanae@bcm.edu

• Top FDA vaccine adviser recuses herself over tie to Moderna.12

• Associate Professor Baylor. She currently serves as the Principal Investigator of the Vaccine and Treatment Evaluation Unit at Baylor College of Medicine.13

• Federal database shows since 2013 $693,001.78 in general payments and $5,315,014.60 in research payments made to “Chi St. Lukes Health Baylor Med Ctr” – 6720 Bertner Ave, Houston, TX from various companies.14

• Dr. El Sahly was appointed as one of three lead investigators for Moderna’s 30,000-person trial in July. Reuters reported that Dr. El Sahly had to recuse herself from an important committee meeting on Oct. 22, 2020.15,16 There are multiple citations of this. e.g. 17, 18, 19 & 20 Ironically, there is no compensation of Dr. El Sahly reported on the openpaymentsdata.cms.gov website. This raises serious questions as to the completeness of the conflict 3 data reported on that site. The University of Florida Conflicts of Interest Program and the Project on Government Oversight reported conflicts of interest of Drs. El Sahly, Monto, and Chaterjee.21,22

Paula Annunziato, M.D

Expertise: Industry

Representative Term: 02/01/2020-01/31/2024

Vice President and Therapeutic Area Head Vaccines Clinical Research Merck North Wales, PA 19454

• Past (or current?) involvement in supervising Moderna’s Covid-19 vaccine clinical trial.23

• Not listed in the openpaymentsdata.cms.gov website.

Acting Chair

Arnold Monto, M.D. Thomas Francis Jr. Collegiate Professor of Public Health Professor of Epidemiology Department of Epidemiology University of Michigan School of Public Health Ann Arbor, MI 48109

• Acting chairman of the committee, Dr. Arnold Monto received $54,114 from 2013 through 2019 from vaccine contenders Sanofi, GlaxoSmithKline, Pfizer, and Shionogi, according to the database. He also received $10,657 from Novartis, which has a deal to manufacture a coronavirus vaccine.24

• Dr. Monto received a total of $194,254 from pharmaceutical companies.25 The largest contributor was Seqirus, a company developing COVID vaccine in Australia.26 The University of Florida Conflicts of Interest Program and the Project on Government Oversight reported conflicts of interest of Drs. El Sahly, Monto, and Chaterjee.27, 28

Archana Chatterjee, M.D., Ph.D.

Expertise: Pediatrics, Infectious Diseases Term: 06/21/2019-01/31/2023

Dean Chicago Medical School Vice President for Medical Affairs Rosalind Franklin University of Medicine and Science North Chicago, IL 60064 4

• A federal database shows that, in 2019, advisory committee member Dr. Archana Chatterjee, for instance, received $23,904 from Pfizer (including Pfizer International LLC), $11,738 from Merck, and $11,480 from Sanofi, each of which is in the race for a coronavirus vaccine. Since 2013, she has received more than $200,000 in consulting fees, travel and lodging, and other payments from those companies and others working on coronavirus vaccines, according to the database.29

• She is a professor of epidemiology at the University of Michigan, which has announced that it is partnering with pharmaceutical company, AstraZeneca on a clinical trial of a potential Covid-19 vaccine.30

• General payments to Dr Chaterjee total $245,810. Associated research funding totals $142,344. Largest funders include: Pfizer Inc., Merck Sharp & Dohme Corporation, Seqirus USA Inc., and AstraZeneca Pharmaceuticals.31 The University of Florida Conflicts of Interest Program and the Project on Government Oversight reported conflicts of interest of Drs. El Sahly, Monto, and Chaterjee.32,33

CAPT Amanda Cohn, M.D.

Expertise: Pediatrics, Vaccines

Term: 02/01/2020-01/31/2024

Chief Medical Officer National Center for Immunizations and Respiratory Diseases Centers for Disease Control and Prevention Atlanta, GA 30333

Telephone: (404) 639-6039 E-mail: acohn@cdc.gov

Hayley Gans, M.D.

Expertise: Pediatrics, Infectious Diseases

Term: 06/21/2019-01/31/2023

Professor of Pediatrics Department of Pediatrics

Stanford University Medical Center Stanford, CA 94305

Holly Janes, Ph.D.

Expertise: Biostatistics

Term: 02/01/2020-01/31/2023 Associate Member Fred Hutchinson Cancer Research Center Vaccine and Infectious Disease Division

Division of Public Health Sciences Seattle, WA 98109 5

Phone: 206.667.6353

Email: hjanes@fredhutch.org

Fax: 206.667.4378

Michael Kurilla, M.D., Ph.D.

Expertise: Infectious Diseases, Pathology

Term: 08/06/2018-01/31/2022

Director, Division of Clinical Innovation National Center for Advancing Translation Sciences National Institutes of Health Bethesda, MD 20852

Email: Michael.kurilla@nih.gov

Myron Levine, M.D., D.T.P.H., F.A.A.P

Expertise: Infectious Diseases Term: 05/09/2018-01/31/2022

Simon & Bessie Grollman Distinguished Professor Associate Dean for Global Health Vaccinology and Infectious Diseases Center for Vaccine Development University of Maryland School of Medicine Baltimore, MD 21201

• Dr. Myron Levine is associate dean for global health, vaccinology, and infectious diseases at the University of Maryland School of Medicine. The school is participating in a clinical trial of a COVID-19 vaccine being developed by Moderna and the National Institute of Allergy and Infectious Diseases.34

• Since 2013, for research in which Levine played a principal role, GlaxoSmithKline has paid the University of Maryland Baltimore Foundation Inc. and another institution more than $2.3 million.35

• Dr. Levine received general payments of $41,635 and associated research funding of $2,314,178. Dr. Levin’s 2019 funding was about six times the mean of similar physicians.36 His largest source of funding was Sanofi Pasteur who is developing a COVID vaccine as above.37

• UM School of Medicine’s Myron M. Levine, MD, DTPH, to Receive Prestigious Lifetime Award for Five Decades of Pioneering Vaccine Research38 6 • Was on a WHO sponsored advisory group that considered feasibility of doing Covid-19 challenge studies in young, healthy volunteers. No conflict of interest declared. Also on the panel was Sheng-Li Shi from WIV.39

H. Cody Meissner, M.D. (aka Herman Meissner)

Expertise: Infectious Diseases

Term: 08/06/2018-01/31/2022

Professor of Pediatrics Tufts University School of Medicine Director, Pediatric Infectious Disease Tufts Medical Center Boston, MA 02111

• Tufts Children’s Hospital – Division of Pediatric Infectious Disease. Head of all clinical trials for all of Tufts Children’s Hospital.40

• Since 2013, Tufts University has been paid general payments of $13,241,677.43 by companies including Pfizer, Boston Scientific, Gyrus Acmi, Inc., Janssen Scientific, Biogen, Inc., Bayer Healthcare, Sanofi-Aventis, Genentech, Otsuka Pharmaceutical, Amgen, Inc.41

• Since 2013, Tufts University has been paid research payments of $34,183,399.06 by companies including Pfizer, Inc., Merck Sharp & Doh, Shire North America, Abiomed, Gilead Sciences, Inc.)42

Paul Offit, M.D. Expertise: Infectious Diseases Term: 02/01/2018-01/31/2022

Professor of Pediatrics Division of Infectious Diseases Abramson Research Building The Children’s Hospital of Philadelphia Philadelphia, PA 19104

• Director of the Vaccine Education Center and an attending physician in the Division of Infectious Diseases at Children’s Hospital of Philadelphia.43

• Since 2013, The Childrens Hospital of Philadelphia has received general payments of $4,559,116.78 and research payments of $32,013,340.94 from companies including Spark Therapeutics, United Therapeutics, Novartis Pharmaceiticals, Amgen, Inc., Pfizer, Inc.44

• Vaccine Safety: Myths and Misinformation. No Conflict of Interest Declared.45

• The science of vaccine safety: Summary of meeting at Wellcome Trust, Conflict of interest statement: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal 7 relationships that could have appeared to influence the work reported in this paper.46

Steven Pergam, M.D. Expertise: Infectious Diseases

Term: 02/01/2020-01/31/2024

Medical Director Infection Prevention Seattle Cancer Care Alliance Seattle, WA 98109

Phone: 206.667.7126 Email: spergam@fredhutch.org

• Associate Professor, Vaccine and Infectious Disease Division, Fred Hutch

• Associate Professor, Clinical Research Division, Fred Hutch47

• Since 2013, Dr. Pergam has received $4167.00 in general payments from Merck and Gilead and $140,311.19 research funding from Merck, Sharp and Dohme. 48

• Potential conflicts of interest. A. L. G. reports personal fees from Abbott Molecular outside the submitted work. S. A. P. reports grant support from Global Life Technologies, Inc, participates in research trials with Chimerix, Inc, and has participated in research with Merck & Co. He is currently participating in a clinical trial sponsored by the National Institute of Allergy and Infectious Diseases (NIAID; U01-AI132004); vaccines for that trial are provided by Sanofi-Aventis.

Andrea Shane, M.D., M.P.H., M.Sc.

Expertise: Pediatric & Infectious Diseases

Term: 02/01/2018-01/31/2022

Professor of Pediatrics Director Division of Pediatric Infectious Diseases Emory University School of Medicine Atlanta, GA 30322

404-727-9880 (direct) 404-727-5642 (main)

Email: ashane@emory.edu

• Medical Director Children’s Healthcare of Atlanta; Curriculum vitae49

• Since 2013, Egleston Childrens Hospital at Emory has received $114,148.01 in general payments and $814,977.27 in research payments from companies including Jazz Pharmaceuticals, Genmark Diagnostics, WL Gore & Associates, etc.50 8

• Since 2013, Emery University Hospital has received $44,133,351.66 in general payments and $170,711,591.68 in research payments. At the top of the research companies are ER Squibb & Sons and Pfizer, Inc.51

• Since 2013, Wesley Woods Center of Emory University has received $41,205.70 in general payments and $3,429,327.48 in research payments. Topping the research companies are E.R. Squibb & Sons and Janssen Research. 52

Paul Spearman, M.D.

Expertise: Pediatric & Infectious Diseases

Term: 05/09/2018-01/31/2022

Director, Division of Infectious Diseases Albert B. Sabin Chair in Pediatric Infectious Diseases Cincinnati Children’s Hospital Medical Center Professor, Department of Pediatrics University of Cincinnati School of Medicine Cincinnati, OH 45229

513-636-4509

Email:Paul.spearman@cchmc.org

• Between 2013-2015, Dr. Spearman received $39,459.84 in research funding from Glaxosmithkline, LLC and Astrazenica. No data available for years 2016-201953

• Since 2013, University of Cincinnati Medical Center has received $2,236,276.81 in general payments and $4,281,617.38 in research payments. Topping the list of companies on both accounts is Pfizer, Inc.54

• Had to be recused from some meetings because his hospital, Cincinnati Children’s Hospital is also a COVID vaccine clinical trial site.55 Dr. Spearman received $39,46060 in associated research funding primarily from Glaxosmithkline, LLC. and AstraZeneca Pharmaceuticals LP.56

• No conflict of interest declared in Warp Speed for COVID-19 Vaccines: Why are Children Stuck in Neutral? 57 Conclusions: Children are at substantial risk of COVID-19. Delays in starting Phase II vaccine clinical trials in children will delay our recovery from COVID-19 and unnecessarily prolong its impact upon children’s health and emotional well-being, their education, and equitable access to opportunities for development and social success, as well as the country’s economy. Understanding the safety, immunogenicity, and efficacy of COVID-19 vaccines in children is critical to protect children and adults. For children, a vaccine has the added benefit of returning them safely to school and extracurricular activities, and allowing them to engage with their world face- 9 to-face once again. Ensuring acceleration of vaccine clinical trials to warp speed for children will be critical in making this our future reality.

Geeta K. Swamy, M.D.

Expertise: Infectious Diseases

Term: 08/06/2018-01/31/2022

Senior Associate Dean Vice Chair for Research & Faculty Development Associate Professor, ObGyn Department of Obstetrics & Gynecology Division of Maternal-Fetal Medicine Duke University Durham, NC 27710

• Since 2013, Dr. Swamy has received general payments of $63,040.09 (Glaxosmithkline, LLC, Sanofi, Pfizer, et al) and research payments of $206,038.64 from Glaxosmithkline, LLC.58

• Since 2013, Duke University Hospital has received $7,599,234.72 in general payments and $40,585,472.53 in research payments from various companies. Pfizer, Inc. contributed general payments of $866,119.65 and research payments of $2,677,484.45.59

• Dr. Swamy had to recuse herself from committee meetings because Duke University, where she is associate vice president for research, is a clinical trial site for the Pfizer-BioNTech and AstraZeneca vaccines.60 Dr. Swamy received payments from pharmaceutical companies totaling $63,040. Her associated research funding totaled $206,039, about three times that of similar physician. Dr. Swamy’s largest sources of funding are Glaxosmithkline, LLC., Sanofi Pasteur Inc., Pfizer Inc. and Novartis Vaccine.61

• Vaccination of pregnant women with respiratory syncytial virus vaccine and protection of their infants. Study funded by Novavax and the Bill and Melinda Gates Foundation.62

Gregg Sylvester, M.D., M.P.H.

Expertise: Alternate Industry Representative

Term: 02/01/2020-01/31/2024

Vice President Medical Affairs Seqirus Inc. Summit, NJ 07901 10

• Chief Medical Officer, Seqirus – Dr Gregg Sylvester has led Seqirus Medical Affairs since 2016, overseeing the global team that scientifically differentiates our vaccines by generating Real World Evidence and presenting Seqirus research to national vaccine recommending organizations.

• According to the Federal database, Seqirus USA, Inc. has made general payments in the sum of $569,854.35 and research payments in the sum of $44,159,881.83. Topping the list of receivers of general payments are Arnold Simon Monto and Archana Chatterjee.63

DIRECTOR

Prabhakara Atreya, Ph.D. Division of Scientific Advisors & Consultants Center for Biologics Evaluation & Research Food and Drug Administration Silver Spring, MD 20993

CBERVRBPAC@fda.hhs.gov

DR. MARION GRUBER Director, FDA Vaccine Research Office

DESIGNATED FEDERAL OFFICER

Kathleen Hayes, M.P.H. Division of Scientific Advisors & Consultants Center for Biologics Evaluation & Research Food and Drug Administration Silver Spring, MD 20993 CBERVRBPAC@fda.hhs.gov

1 https://www.nih.gov/news-events/news-releases/nih-clinical-trial-investigational-vaccine-covid-19-begins

2 https://www.ott.nih.gov/resources

3 https://www.ott.nih.gov/royalty/information-nih-inventors

4 https://www.ott.nih.gov/resources

5 https://www.ott.nih.gov/royalty/information-nih-inventors

6 https://www.icandecide.org/wp-content/uploads/2020/08/NIH-FOIA-53821-Complete-Response-RS.pdf

7 https://investors.modernatx.com/node/8671/pdf

8 https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-supply-agreementus-government-initial-100

9 https://crsreports.congress.gov/product/pdf/IN/IN11446

10 https://www.fda.gov/advisory-committees/vaccines-and-related-biological-products-advisorycommittee/roster-vaccines-and-related-biological-products-advisory-committee 11 https://www.ghwatch.org/who-watch/h1n1.html

12 https://www.foxnews.com/us/hana-sahly-vaccine-adviser-resign-covid

13 https://www.bcm.edu/people-search/hana-el-sahly-21052 11

14 https://openpaymentsdata.cms.gov/hospital/450193

15 https://www.bizjournals.com/boston/news/2020/09/25/fda-official-involved-in-moderna-trial-steps-aside.html

16 https://www.reuters.com/article/healthcoronavirus-vaccines-fda/exclusive-top-adviser-steps-aside-from-fdacovid-19-vaccine-reviews-over-potential-conflict-idUSL2N2GK284

17 https://www.statnews.com/2020/10/20/dry-technical-but-important-why-an-fda-advisory-panels-meeting-oncovid-19-vaccines-matters/

18 https://www.nbcdfw.com/news/coronavirus/texan-involved-in-covid-19-vaccine-trials-advises-against-halfdoses/2521936/

19 https://www.pbs.org/newshour/health/watch-live-fda-advisory-committee-assesses-covid-19-vaccinedevelopment

20 https://www.bizjournals.com/boston/news/2020/09/25/fda-official-involved-in-moderna-trial-steps-aside.html

21 https://coi.ufl.edu/2020/10/26/some-fda-advisors-tapped-to-review-coronavirus-vaccines-received-paymentsfrom-vaccine-companies/

22 https://www.pogo.org/investigation/2020/10/some-fda-advisors-tapped-to-review-coronavirus-vaccinesreceived-payments-from-vaccine-companies/

23 https://finance.yahoo.com/news/fda-vaccine-committee-head-steps055718018.html?guccounter=1&guce_referrer=aHR0cHM6Ly9kdWNrZHVja2dvLmNvbS8&guce_referrer_sig=AQA AALNseSAkcAU_oXgLmONgHMz3p4FUoRtEgZv6xLlCKnvY8bO_SPG8CWFhdbvZULO0xruuDmy7LlRVSQuQ_uWNGkX o58YlBrjD2co7KOVu2CRMOwippqce1pb6QhT5efYM5OMtuWyPQ9K3EzyR5yg-u1v_7VSbFCdGLHIFDP1kiJhj

24 https://openpaymentsdata.cms.gov/physician/1311454 25 Id.

26 https://www.seqirus.us/news/covid19-update

27 https://coi.ufl.edu/2020/10/26/some-fda-advisors-tapped-to-review-coronavirus-vaccines-received-paymentsfrom-vaccine-companies/

28 https://www.pogo.org/investigation/2020/10/some-fda-advisors-tapped-to-review-coronavirus-vaccinesreceived-payments-from-vaccine-companies/

29 https://coi.ufl.edu/2020/10/26/some-fda-advisors-tapped-to-review-coronavirus-vaccines-received-paymentsfrom-vaccine-companies/

30 https://www.uofmhealth.org/news/archive/202009/u-m-conduct-clinical-trial-test-astrazeneca-covid-19-vaccine

31 https://openpaymentsdata.cms.gov/physician/803928

32 https://coi.ufl.edu/2020/10/26/some-fda-advisors-tapped-to-review-coronavirus-vaccines-received-paymentsfrom-vaccine-companies/

33 https://www.pogo.org/investigation/2020/10/some-fda-advisors-tapped-to-review-coronavirus-vaccinesreceived-payments-from-vaccine-companies/

34 https://www.medschool.umaryland.edu/profiles/Levine-Myron/

35 https://openpaymentsdata.cms.gov/physician/1098730

36 Id.

37 https://www.sanofi.com/en/about-us/our-stories/sanofi-s-response-in-the-fight-against-covid-19

38 https://www.medschool.umaryland.edu/CVD/News-and-Events/2019/UM-School-of-Medicines-Myron-MLevine-MD-DTPH-to-Receive-Prestigious-Lifetime-Award-for-Five-Decades-of-Pioneering-Vaccine-Research.html

39 https://pubmed.ncbi.nlm.nih.gov/32857836/

40 https://www.tuftschildrenshospital.org/Patient-Care-Services/Departments-and-Services/InfectiousDisease/Overview

41 https://openpaymentsdata.cms.gov/hospital/220116

42 https://openpaymentsdata.cms.gov/hospital/220116

43 https://www.chop.edu/doctors/offit-paul-a

44 https://openpaymentsdata.cms.gov/hospital/393303

45 https://pubmed.ncbi.nlm.nih.gov/32857836/

46 https://www.sciencedirect.com/science/article/pii/S0264410X20300396?via%3Dihub

47 https://www.fredhutch.org/en/faculty-lab-directory/pergam-steven.html

48 https://openpaymentsdata.cms.gov/physician/44476

49 https://fda.report/media/117726/VRBPAC-AndreaLShane-CV.pdf 12

50 https://openpaymentsdata.cms.gov/hospital/113300

51 https://openpaymentsdata.cms.gov/hospital/110010

52 https://openpaymentsdata.cms.gov/hospital/110203

53 https://openpaymentsdata.cms.gov/physician/1036685

54 https://openpaymentsdata.cms.gov/hospital/360003 55 https://www.statnews.com/2020/10/20/dry-technical-but-important-why-an-fda-advisory-panels-meeting-oncovid-19-vaccines-matters/

56 https://openpaymentsdata.cms.gov/physician/1036685

57 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543330/pdf/ciaa1425.pdf

58 https://openpaymentsdata.cms.gov/physician/292920

59 https://openpaymentsdata.cms.gov/hospital/340030

60 https://www.statnews.com/2020/10/20/dry-technical-but-important-why-an-fda-advisory-panels-meeting-oncovid-19-vaccines-matters/

61 https://openpaymentsdata.cms.gov/physician/292920

62 https://pubmed.ncbi.nlm.nih.gov/32726529/

63 https://openpaymentsdata.cms.gov/company/100000136554

Category:

Activism, vaccines, Viruses

Wisconsinites: Take Action and Urge Committee Vote on Consumer Access to Complementary & Alternative Health Practitioners Bill, AB 86

https://nationalhealthfreedomaction.salsalabs.org/voteonwisafeharborbill

We urgently need your help to convince the Wisconsin Assembly Health Committee to schedule a vote to pass AB 86 out of committee.  The bill had a public hearing back in July but the Committee has not taken a vote and moved it out of Committee yet.  This is the last step needed before the bill can move to the full Assembly Floor for a final floor vote!  Last year this bill passed the Assembly Floor but had to start over due to COVID.  This year it already passed the Senate Committee and Senate Floor (SB 98).  We’re now waiting on the Assembly Health Committee to keep it moving.  We’ve waited long enough!  Since the public hearing, we even accepted amendments to the bill to make sure all issues have been addressed and now we need your help! Assembly legislators and Health Committee Members need to hear from you to convince them to schedule a vote on AB 86 asap!
CLICK TO TAKE ACTION – SUPPORT WI AB 86
Support AB 86/SB 98, the Complementary and Alternative Health Care Practitioners Exemption bill, because it:

  • Protects your access to services provided by practitioners of complementary and alternative health in Wisconsin such as herbalists, traditional naturopaths, nutritional consultants, homeopaths, Reiki practitioners, Ayurveda practitioners, and many more.
  • Enables practitioners to provide services without fear of being charged with practice of medicine without a license as long as they avoid a list of prohibited acts and give out proper disclosures.
  • Adds clarity to Wisconsin law and updates it to reflect what is happening already!
  • Already passed unanimously out of the Senate Insurance, Licensing and Forestry Committee and it passed the Senate, as amended, on a unanimous voice vote on April 14.
  • Last session, it passed the Assembly Health Committee, the Assembly Floor and the Senate Committee on Health before stalling in the Senate due to COVID-19.
  • 11 other states already protect the practices of many wonderful complementary and alternative practitioners who are providing great services to health seekers – Wisconsin should too!

Spread the word about SB 98/AB 86.  Please forward this email to your friends and family so they can Take Action to support SB 98/AB 86 too.

THANK YOU for your commitment to Health Freedom!  If you have questions, contact us at info.nhfa@nationalhealthfreedom.org.

Category:

Activism

“Vaccine” Mandate Temporarily Blocked But White House Tells Businesses to Ignore Federal Court Order & A Senate Health Committee Hearing: Walensky Doesn’t Answer One Question – Not One

https://www.theblaze.com/news/biden-court-order-vaccine-mandate

White House tells businesses to ignore federal court order and implement vaccine mandate anyway

Carlos Garcia

November 08, 2021

The Biden administration said that businesses should ignore a federal court ruling against his vaccine mandate and implement it anyway.

“We think people should not wait,” said White House Deputy Press Secretary Karine Jean-Pierre during Monday’s media briefing. “They should continue to move forward and make sure that they’re getting their workplace vaccinated.”

(See link for article)

https://www.theblaze.com/news/vaccine-mandate-lawsuit-texas-court

Federal Court of Appeals temporarily blocks Biden’s vaccine mandate based on ‘grave statutory and constitutional issues’

Paul Sacca

November 06, 2021

Excerpts:

Texas Gov. Greg Abbott announced on Saturday afternoon that the Federal Court of Appeals issued a temporary halt to President Joe Biden’s “vaccine” mandate….

Emergency hearings will take place soon.

“We will have our day in court to strike down Biden’s unconstitutional abuse of authority.”  – Gov. Abbott

Texas was one of 26 states that launched lawsuits challenging the Biden administration’s vaccine mandate that will be enforced by the Occupational Safety and Health Administration (OSHA).  (See link for article)

________________

Watch Sharyl Attkison on Full Measure for an excellent 9 minute report on the “Vaccine” mandate.

**Comment**

Meanwhile, Biden Labor Secretary Claims OSHA COVID “Vaccine” Rule Isn’t A Mandate.

“This new rule is illegal and unconstitutional. It circumvents the normal legal process, along with Congress, to claim emergency powers to impose a mandate on American business,” said Rick Esenberg, president and general counsel at the Wisconsin Institute for Law & Liberty, which is representing two businesses that are suing the administration over the standard, according to The Epoch Times.

**Comment**

Tell OSHA the Emergency Rule should NOT be adopted as a final standard!

OSHA is requesting public comments for the next 30 days as to whether the Emergency Temporary Standard (ETS) agency rule for employer COVID vaccine, masking, and testing requirements, should become a final standard.  Although the ETS, aka Biden’s Mandate, is to take effect immediately on November 5, 2021, OSHA states that it also serves as a proposal under statute for a final standard.  We do not want this to become a final standard!

In addition, OSHA is requesting comments on the rule’s entire content including such things as whether to apply the standard in the future to small businesses; “OSHA encourages commenters to explain why they prefer or disfavor particular policy choices, and include any relevant studies, experiences, anecdotes or other information that may help support the comment.”

Go here to give a public comment.

Reasons to Oppose the ETS: 

  • Personal health care decisions should not be dictated by employment requirements.
  • It is the result of Federal overreach by the Biden Administration using an agency to accomplish what cannot legally be done by a President.
  • As discussed by the plaintiffs in BST Holdings, et al. v. OSHA, it exceeds OSHA’s authority under its enabling statute; it exceeds Congress’s authority under the Commerce Clause; and it exceeds Congress’s authority under the nondelegation doctrine.
  • For background on the ETS, read NHFA’s post opposing President Biden’s Mandate here.  OSHA was tasked with implementing the mandate.

Please submit comments despite the stay of enforcement of the ETS (the “Mandate”) as ordered by the 5th Circuit in BST Holdings, et al. v. OSHA, on Saturday, November 6.  As the order makes clear, the stay of enforcement is only valid “pending further action by the court.” 

____________________

http://

Nov. 4, 2021

Senator Cassidy (R-LA) grills CDC Director Walensky – Who Doesn’t Answer a Single Question – Not One

At a recent Senate Health Committee hearing, Sen. Bill Cassidy (R-LA) asked CDC Director Rochelle Walensky a number of important questions about natural immunity and why CDC employees are still working remotely if they have been “vaccinated,” and are wearing PPE (personal protective equipment).

  • Recent publications show that 6 to 8 months out 92% of those with natural immunity have T cells, B cells, and antibodies that are adequate to protect.
  • CDC has access to electronic health records (EHR) as to who tests positive for COVID.
  • The reason the CDC won’t state that natural immunity confers protection against future infections is because they’ve decided not to look.
  • While Walensky blathers on with insignificant information, Cassidy drills down by pointing out the CDC could prospectively look at the data, and follow the EHR to determine this crucial but ignored fact of natural immunity.
  • Walensky claims there would be biases.
  • Cassidy states that there could also be empirical clinical data used, not just lab results due to EHRs.
  • Cassidy rightly states the American people “intuitively understand this, and they feel like we are being willfully blind to it.” 
  • Then, for the blockbuster: Cassidy simply asks what percentage CDC employees have been “vaccinated.” (In May a senate hearing showed that only a little over half got the jab.)
  • Instead of answering the simple question, Walensky rambles on about their efforts to “vaccinate.”
  • Cassidy states that North of 75% of CDC employees are still working remotely.  He asks if this is correct and Walensky, who is the head of the CDC, states she doesn’t know that number off the top of her head.
  • Not to be undone, Cassidy then asks when you go down the hallway, are there empty desks?
  • Walensky, desperate to stay on script, reiterates she doesn’t have the numbers of the top of her head.
  • Cassidy states that a recent government accountability office (GAO) report shows there has been no coordinated response from the federal government to get federal employees back into work.  He points out that while teachers are back to work, he has no clue how ‘vaccinated” lab workers wearing PPE would consider themselves eligible to stay at home.
  • Cassidy points out that it doesn’t bode well with the public if federal health agencies don’t have enough confidence in the “immunization” & PPE to go back to work.
  • Lastly Cassidy points out a letter he & Senator King submitted in early February on genomic surveillance that has yet to be answered.
Cassidy gets a 10, Walensky, a 0.

I’ve posted previously that Fauci, Collins, and Walensky are expert Wordsmiths. They redirect, filibuster, ignore questions, and redefine and manipulate words, definitions, and statistics. They’ve been expertly deceiving the public for decades.

 

Category:

Activism, vaccines, Viruses

Physician to FDA, CDC: In 20 Years of Practicing Medicine, ‘I’ve Never Witnessed So Many Vaccine-Related Injuries’ & VAERS Backlogged

https://childrenshealthdefense.org/defender/dr-patricia-lee-fda-cdc-vaccine-related-injuries

Physician to FDA, CDC: In 20 Years of Practicing Medicine, ‘I’ve Never Witnessed So Many Vaccine-Related Injuries’

Dr. Patricia Lee, a licensed physician in California, said her experience with patients harmed by the COVID vaccine “does not comport with claims made by federal health authorities regarding the safety of COVID-19 vaccines.”

© [10/13/21] Children’s Health Defense, Inc. This work is reproduced and distributed with the permission of Children’s Health Defense, Inc. Want to learn more from Children’s Health Defense? Sign up for free news and updates from Robert F. Kennedy, Jr. and the Children’s Health Defense. Your donation will help to support us in our efforts.

An ICU physician detailed her concerns about the adverse reactions, including deaths, she witnessed in people who had received a COVID vaccine.

In a letter dated Sept. 28 to officials at the U.S. Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC), an ICU physician detailed her concerns about the adverse reactions, including deaths, she witnessed in people who had received a COVID vaccine.

Dr. Patricia Lee, a licensed physician in California, said her experience with patients harmed by the vaccine:

“does not comport with claims made by federal health authorities regarding the safety of COVID-19 vaccines.”

In the letter, Lee described observing “entirely healthy individuals suffering serious, often fatal, injuries,” including transverse myelitis, resulting in quadriplegia, pneumocystis pneumonia, multi-system organ failure, cerebral venous sinus thrombosis, postpartum hemorrhagic shock and septic shock.

Lee, a practicing physician for more than 20 years, said she “never witnessed so many vaccine-related injuries until this year.”

Lee told Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, and Dr. Tom Shimabukuro with the CDC’s COVID-19 Vaccine Task Force Vaccine Safety Team, that while “causation is difficult to prove definitively, it is my clinical judgment that each of these injuries were caused by a COVID-19 vaccine, because there was no other plausible explanation for these injuries other than the fact that the patients had recently been vaccinated.”

Lee acknowledged that her report reflects the experience of a single physician. However, she wrote, it appears “statistically improbable” that any one physician should witness this many COVID-19 vaccine injuries if the federal health authority claims regarding the vaccines’ safety were accurate.

“I can no longer silently accept the serious harm being caused by the COVID-19 vaccines,” Lee concluded. “It is my sincere hope that the reaction to this letter will not be to focus on me, but rather to focus on addressing the serious safety issues with these products that, without doubt, you have either missed or are choosing to ignore.”

Since the issuing of the original letter, Lee’s attorneys sent another letter to the CDC and FDA saying that the agencies’ “failure to respond is highly concerning,” adding that they are seeking a response so they can “arrange a discussion and information gathering session between Dr. Lee and the appropriate representatives at the CDC and FDA.”

Read both letters here.

_____________

https://www.newstarget.com/2021-10-31-hundreds-of-thousands-covid-vaccine-injuries-backlogged-not-entered-into-vaers

Hundreds of thousands of covid vaccine injuries BACKLOGGED and not yet entered into VAERS … far greater numbers of injuries and deaths are still to come

10/31/2021 / By Lance D Johnson
Hundreds of thousands of covid vaccine injuries BACKLOGGED and not yet entered into VAERS … far greater numbers of injuries and deaths are still to come

On the latest episode of “Doctors and Scientists,” Dr. Brian Hooker Ph.D., P.E., was interviewed Dr. Jessica Rose, Ph.D. to discuss the failures of the vaccine injury surveillance system that was set up by the CDC and FDA over thirty years ago. Dr. Rose is an expert in bio-mathematics and molecular research.

In January of 2021, she utilized her skills as a computational biologist and began analyzing data in the Vaccine Adverse Events Reporting System (VAERS). Each week, she downloaded publicly-available data sets from VAERS, comparing inputs week-to-week. She discovered that vaccine injury reports went missing from one week to the next. Each week, the data is updated in the VAERS system. She found that some of the data is overwritten, vanished from the system. She also found that “hundreds of thousands” of covid vaccine injury reports were backlogged and did not appear in a timely manner to alert healthcare professionals to serious issues with the vaccine. (See link for article)

______________

Important excerpts:

Some issues are under-reported by a factor of thirty-one, and other, more common side effects can be under-reported by a factor of one hundred.

This might be the biggest flaw with the system yet: The agencies that are supposed to oversee the data and alert the public to medical atrocities are the same entities trying to push a narrative forward – that vaccines are “safe and effective.”

_________________

https://rumble.com/voalls-dr.-richard-fleming-pfizer-vaccine-causes-blood-clots-under-microscope.html  Video Here

COVID injection DANGER: Pfizer jab causes blood clots under microscope

“Add the Pfizer vaccine and the red blood cells lose their oxygen carrying capacity and the red blood cells start to clot... This is exactly what we are seeing with the VAERS reporting. This is exactly what we are seeing with neurologic harm, with cardiac harm, with blood clots occurring in the body. This is proof positive that these vaccines cause this type of damage under the microscope just by simply being added to the blood of a human being…

I think it is time the FDA and CDC do their job instead of giving it lip-service.” Dr. Richard Flemming

For more:

Hypercoagulation (thick blood) and blood clotting has been found in Lyme/MSIDS patients. Many patients improve on blood thinners.

Category:

Activism, vaccines, Viruses

Clinical Presentation of Lyme Disease in Patients Living in Germany – Same Story, Different Country

https://danielcameronmd.com/presentation-lyme-disease-patients-germany/

Clinical presentation of Lyme disease in patients living in Germany

Lyme disease presentation in man from Germany holding his hands over his face.
In their article, entitled “Neuropsychiatric and Psychological Symptoms in Patients with Lyme Disease: A Study of 252 Patients,” Hündersen and colleagues describe the clinical presentation, diagnostic process and treatment regimens for 252 Lyme disease patients. [1]
By

The authors collected data via an online questionnaire from 252 Lyme disease patients and a control group of 267 healthy individuals living in Germany to examine the clinical presentation, including neuropsychiatric and psychological symptoms.

The findings revealed that “Lyme disease can cause diverse psychological and neuropsychiatric symptoms. These include limitations in quality of life, sleep, attention, and memory, as well as depressive symptoms.”

Time to diagnosis

The majority of the patients were diagnosed with Lyme disease based on ELISA (53.2%), Western blot (43.7%), and lymphocyte transformation test results (41.7%).

Out of the 252 participants, nearly half (45.5%) recalled an erythema migrans rash, while 74% recalled a tick bite “that possibly triggered Lyme disease.”

It took approximately 8 years to receive a diagnosis following the tick bite.

On average, patients visited almost 8 physicians to obtain a diagnosis.

It took approximately 8 years to receive a diagnosis following the tick bite.  Less than half (46%) received their diagnosis within the first 5 years after the onset of symptoms.

Co-infections

The majority of participants were not diagnosed with or tested for a co-infections.

“A total of 25% of the sample stated that they had (exactly one) co-infection,” the authors explain, while 15% reported having 2 co-infections.

“For patients that suffered from co-infections, Chlamydia infection was particularly common (34.9%), as was the Epstein–Barr virus (34.9%).”

Treatment

Out of the 252 participants, 168 received antibiotic treatment that lasted at least 3 weeks.

Symptoms improved for nearly 73% of these patients.

93% of participants reported a relapse of symptoms after the completion of antibiotic therapy.

“The type of treatment was oral in most cases (47.6%), or a combination of oral and intravenous therapy (48.8%),” according to the authors.

Intravenous antibiotic therapy was prescribed in only 3.6% of the cases.

Authors Conclude:

  • “It became clear that Lyme disease is often diagnosed very late.”
  • “It appears that people suffering from Lyme disease have significantly lower quality of life and sleep and show cognitive impairments when it comes to attention and memory.”
  • “This study shows that 3.1% of Lyme patients were satisfied with their lives and that 37% scored in the lower third of the quality-of-life scale.”
  • “It was also shown that Lyme patients tend to have depressive symptoms.”
References:
  1. Hündersen F, Forst S, Kasten E. Neuropsychiatric and Psychological Symptoms in Patients with Lyme Disease: A Study of 252 Patients. Healthcare (Basel). 2021 Jun 14;9(6):733. doi: 10.3390/healthcare9060733. PMID: 34198647; PMCID: PMC8232147.

________________

**Comment**

This article, right here, encapsulates dire issues that have remain untouched for over 40 years.

  • Abysmal testing is still relied upon for diagnosis
  • Having the EM rash and remembering a tick bite happen far less than we are being told
  • People are still diagnosed and treated late, even though everyone and their dog knows this is a problem
  • Eight years is a long time to suffer, allowing pathogens to travel everywhere in the human body causing untold damage
  • Three weeks of antibiotics is a complete JOKE and is laughable if the consequences weren’t so dire
  • Most were not tested for coinfections.  Since testing for coinfections is just as abysmal as for Lyme – these patients saved a lot of money.  The minus, of course, is not understanding that cases with coinfection involvement are far more difficult to treat and require far more medications for a longer period of time. Lyme literate doctors understand this fact and will diagnose and treat clinically (based upon symptoms – not tests alone)
  • The fact their symptoms improved in 3 weeks doesn’t mean they should end treatment.  In fact, for those with a brain, it indicates antibiotic treatment works and should be continued until they don’t work, and then, they should be changed, not stopped as coinfections often need addressing and require different meds
  • 93% relapsing should prove to the deniers once and for all that the measly 21 days of doxycycline clearly isn’t working. 
  • 93% relapsing should also put to rest the myth that only 10-2-% go onto suffer persistent symptoms. When you count those who were diagnosed and treated late, as these patients were, it is an astounding 60% that go on to suffer debilitating symptoms.
  • The life-altering, debilitating symptoms these poor people suffer with show that this 40-year old experiment must end.  This is barbarism on a scale similar to the Tuskagee experiment

Category:

Activism, Lyme, research, Treatment